Select Page

For more than 20 years, the Clinique médicale l’Actuel, under the direction of Dr. Réjean Thomas, has been bringing together healthcare professionals, with a focus in virology, to learn from guest experts and discuss the most relevant clinical practice challenges facing them today.

HIV and Renal Health

with Dr. Patrice Junod and Dr. Réjean Thomas

PROGRAM EXCERPT

HIGHLIGHTS

  • The impact of protease inhibitors on renal function.
  • Renal function monitoring algorithm for treated or non-treated HIV-infected patients.
  • Application of the monitoring algorithm to the case of an HIV-infected patient suffering from numerous comorbidities.

This activity is supported by
an educational grant from:

janssen-logo

SUMMARY

PARTICIPANTS

During this presentation, Dr. Patrice Junod, from the Clinique médicale l’Actuel, explains briefly the impact of protease inhibitors on renal health.

He also presents an algorithm to monitor renal function and the case of an HIV patient who suffers from numerous comorbidities and in which this algorithm is used.

Réjean Thomas, MD

Réjean Thomas, MD

Interviewer

CEO | Founder
Clinique médicale l’Actuel:
Centre of Excellence HIV – STI – Hepatitis
Affiliated with the Centre hospitalier de l’Université de Montréal (CHUM)
Québec, Canada

Patrice Junod, MD

Patrice Junod, MD

Interviewee

Clinique médicale l’Actuel
Montréal, Québec, Canada

COMPLETE PROGRAM

Only Logged in users can see the full program
COMPLETE SLIDE DECK

CASE STUDY

ALGORITHM
DISCLOSURE

ViroChannel has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.


Réjean Thomas, MD has a financial interest/relationship or affiliation in the form of: Advisory: AbbVie, Bristol-Myers Squibb Janssen, Gilead, Merck, ViiV Healthcare.

Patrice Junod, MD has a financial interest/relationship or affiliation in the form of: Consultant: AbbVie, Janssen, Gilead, Merck, ViiV Healthcare.


Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses. No responsibility is taken for errors or omissions. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

[comment]